IL284666A - New peptides and their uses - Google Patents

New peptides and their uses

Info

Publication number
IL284666A
IL284666A IL284666A IL28466621A IL284666A IL 284666 A IL284666 A IL 284666A IL 284666 A IL284666 A IL 284666A IL 28466621 A IL28466621 A IL 28466621A IL 284666 A IL284666 A IL 284666A
Authority
IL
Israel
Prior art keywords
novel peptides
peptides
novel
Prior art date
Application number
IL284666A
Other languages
English (en)
Hebrew (he)
Inventor
Elizabeth Cary MILLER
Adriane M Antler
Thomas G Rowan
Anthony M Insogna
Nikolaos C George
Nazneen Dewji
Original Assignee
Cenna Biosciences Inc
Elizabeth Cary MILLER
Adriane M Antler
Thomas G Rowan
Anthony M Insogna
Nikolaos C George
Nazneen Dewji
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cenna Biosciences Inc, Elizabeth Cary MILLER, Adriane M Antler, Thomas G Rowan, Anthony M Insogna, Nikolaos C George, Nazneen Dewji filed Critical Cenna Biosciences Inc
Publication of IL284666A publication Critical patent/IL284666A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
IL284666A 2019-01-07 2021-07-06 New peptides and their uses IL284666A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962789114P 2019-01-07 2019-01-07
PCT/US2020/012323 WO2020146236A1 (en) 2019-01-07 2020-01-06 Novel peptides and uses thereof

Publications (1)

Publication Number Publication Date
IL284666A true IL284666A (en) 2021-08-31

Family

ID=71520880

Family Applications (1)

Application Number Title Priority Date Filing Date
IL284666A IL284666A (en) 2019-01-07 2021-07-06 New peptides and their uses

Country Status (9)

Country Link
US (1) US20220064214A1 (cg-RX-API-DMAC7.html)
EP (1) EP3908307A4 (cg-RX-API-DMAC7.html)
JP (2) JP2022516574A (cg-RX-API-DMAC7.html)
KR (1) KR20220004618A (cg-RX-API-DMAC7.html)
CN (2) CN113853382A (cg-RX-API-DMAC7.html)
AU (2) AU2020207203A1 (cg-RX-API-DMAC7.html)
CA (1) CA3125552A1 (cg-RX-API-DMAC7.html)
IL (1) IL284666A (cg-RX-API-DMAC7.html)
WO (1) WO2020146236A1 (cg-RX-API-DMAC7.html)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US6777388B1 (en) * 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US6660843B1 (en) * 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US20030077740A1 (en) * 2001-03-05 2003-04-24 Schubert David R. Presenilin/Crk binding polypeptides (PCBP) and methods of use thereof
US8129334B2 (en) * 2006-03-31 2012-03-06 The Regents Of The University Of California Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
JP2013526518A (ja) * 2010-05-13 2013-06-24 ザ ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション Ｍｃｉおよびアルツハイマー病の処置
CN106456799B (zh) * 2014-06-03 2020-05-22 江苏佳瑞生物技术有限公司 肽-药物偶联物

Also Published As

Publication number Publication date
EP3908307A1 (en) 2021-11-17
CA3125552A1 (en) 2020-07-16
JP2022516574A (ja) 2022-02-28
EP3908307A4 (en) 2022-10-12
CN114437173A (zh) 2022-05-06
CN113853382A (zh) 2021-12-28
JP2025041635A (ja) 2025-03-26
AU2026200229A1 (en) 2026-02-05
US20220064214A1 (en) 2022-03-03
AU2020207203A1 (en) 2021-08-19
KR20220004618A (ko) 2022-01-11
WO2020146236A1 (en) 2020-07-16

Similar Documents

Publication Publication Date Title
IL294052B2 (en) Fluoroalkyl oxadiazoles and their uses
GB2603645B (en) Polypeptides having anti-senescent effects and uses thereof
IL287782A (en) 33cd-binding polypeptides and their uses
IL290414A (en) atf5 peptide variants and uses thereof
SG11202006669RA (en) Peptides and uses thereof
GB2600592B (en) Polypeptide and use thereof
IL288412A (en) peptides
EP3882263A4 (en) GLUCAGON DERIVED PEPTIDE AND USE THEREOF
IL287503A (en) Thio-semicarbazide compounds and their use
GB201819200D0 (en) Polypeptide and uses thereof
IL282676B1 (en) New dipeptide compounds and their uses
GB201904720D0 (en) Peptide synthesis and modification
EP3947418C0 (en) PEPTIDES AND THEIR USE
AU2020234373A1 (en) Novel peptide and use thereof
GB201918693D0 (en) Peptide
SG11202007887VA (en) Cyclic peptides and uses thereof
IL290019A (en) Peptides to regulate melanocytes
EP3996737A4 (en) PEPTIDES AND THEIR USES
GB201914682D0 (en) Novel anti-cancer peptides and uses thereof
IL284666A (en) New peptides and their uses
IL290401A (en) Peptide antigens and their uses
HK40063851A (en) Novel peptides and uses thereof
AU2019902437A0 (en) Peptides and uses thereof
AU2019902436A0 (en) Peptides and uses thereof
HK40041704A (en) Peptides and uses thereof